PROM1 and glioblastoma: Similarly, we found that treatment with high dose of DCA (5 mM) led to a depletion in cell numbers of ~ 50% in CD133/PROM1HIGH patient-derived GBM cells (p < 0.0001; Additional file 1: Figure 4A).